Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2026-03-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于2026年度重药控股下属子公司融资计划的公告
Capital/Financing Update Classification · 100% confidence The document is an announcement from a company about its subsidiary's financing plan for the year 2026. It discusses the application for a credit facility from banks and financial institutions, including the total amount and terms. There is no financial statement or detailed financial data presented, nor is it a report or presentation. The content clearly relates to capital raising or financing activities. The document length is short and it is an announcement, not a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-03-10 Chinese
第九届董事会第二十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 22nd meeting of the 9th Board of Directors of Zhongyao Holdings Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and references other related announcements for financing plans and guarantees. The content focuses on board meeting decisions and approvals, including financing plans and compliance reports, rather than presenting full financial data or detailed reports. The document is an official disclosure of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short (1199 characters), and it is not a report itself but a meeting resolution announcement. Therefore, the correct classification is MANG with high confidence.
2026-03-10 Chinese
关于为控股子公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding guarantees provided by the parent company for bank credit applications of its subsidiaries. It includes extensive financial data such as asset-liability ratios, guarantee amounts, and financial figures for 2025 (unaudited). The document also references board resolutions and shareholder meeting requirements related to the guarantee plan. The content focuses on financing guarantees and credit support rather than financial results, management changes, or legal proceedings. It is not a full financial report, earnings release, or audit report. The document is a formal announcement about capital/financing activities, specifically guarantees for bank credit, which fits the Capital/Financing Update category (CAP). The document length is substantial and contains detailed financial data related to financing guarantees, supporting this classification with high confidence.
2026-03-10 Chinese
关于为全资子公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the provision of guarantees by the parent company for bank credit applications of its wholly-owned subsidiaries. It includes financial data such as asset-liability ratios, guarantee amounts, and board meeting resolutions approving the guarantees. The document is an announcement of a corporate financing-related activity, specifically about guarantees for bank credit, which falls under capital or financing updates. It is not a full financial report, audit report, or earnings release, nor is it a regulatory filing or a report publication announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2026-03-10 Chinese
关于控股子公司重药股份拟注册债务融资产品计划的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Chongqing Pharmaceutical Holdings Co., Ltd. regarding the planned registration of new debt financing products by its controlling subsidiary. It details the types of debt instruments (medium-term notes and ultra-short-term financing bonds), their issuance scales, terms, purposes, and authorization matters. The document is a formal public announcement about financing plans and approvals, not a financial report or detailed financial statements. It does not contain actual financial data or results but rather informs about upcoming capital raising activities and related approvals. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2354 characters, which is consistent with an announcement rather than a full report.
2026-03-10 Chinese
关于回购股份进展的公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from the company 重药控股股份有限公司 regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with regulatory requirements. The document references specific dates and regulatory guidelines related to share buybacks. It does not contain financial statements or comprehensive financial data but focuses solely on the update of the share repurchase activity. Given the content and the nature of the announcement, this fits the category of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares.
2026-03-02 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.